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Object. Most surgical procedures are associated with a learning curve in which the success rate is lower early in the 
experience before mistakes have been identified and modifications made to the procedure. Negative results obtained early 
in a trial’s learning curve may be a matter of timing rather than a reflection of the procedure’s effectiveness. The recently 
published results of the Endoscopic Shunt Insertion Trial (ESIT) represent the notion that endoscopically placed shunts 
were no more likely to survive than conventionally placed shunts. This negative result may be due to inexperience in per­
forming endoscopic surgeries.
Methods. Surgical experience was assessed in two ways. Shunt survival rates were compared between cases treated 
endoscopically in the 1st and last years of the ESIT. The effect of center volume was evaluated using a Cox proportional 
hazard model in which the following variables were analyzed: age at registration, the diagnosis of myelomeningocele, head 
size, method of shunt placement (endoscopic compared with conventional), and center volume.
There was no difference in survival (endurance) of the shunt between patients enrolled in the 1st and last years (log 
rank = 0.08, p = 0.77). Likewise, no variable in the Cox multivariate model, including center volume, was a significant fac­
tor in predicting shunt survival.
Conclusions. The primary result of the ESIT was found to be internally valid. The fact that endoscopic shunt placement 
did not benefit patients evaluated in the study was not due to early timing of the trial. Any learning curve among the par­
ticipating surgeons did not adversely affect the results.
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y  y  y d ro c e p h a lu s  is arguably the most common dis- 
I— I  order in pediatric neurosurgery. Treatment usually 
A  A  involves placement of a shunt system, most com­
monly a ventriculoperitoneal one. Recently, an RCT was 
completed in which endoscopic-assisted placement of the 
ventricular catheter was compared with the conventional 
placement method.15 The main outcome was shunt failure, 
defined as obstruction, overdrainage, loculation, or infec­
tion. The investigators found no statistically significant 
benefit to using an endoscope to place the ventricular 
catheter. Because many new surgical procedures, includ­
ing endoscopic shunt placement, are associated with a 
learning curve, we considered the possibility that the lack 
of benefit in patients who underwent endoscopic shunt 
surgery may have been the result of starting the trial too 
early, while surgeons were still learning the procedure.
The RCT is generally accepted as the best trial design for 
determining the efficacy of therapeutic (medical or surgi-
Abbreviations used in this paper: EC-IC = extracranial-intracra- 
nial; ESIT = Endoscopic Shunt Insertion Trial; RCT = randomized 
clinical trial.
cal) interventions. Because of its rigorous design and con­
current control group, it minimizes error (both random and 
systematic, otherwise known as bias) and tends to distrib­
ute all known and unknown prognostic factors (confound- 
ers) equally between the treatment groups. Thus, any dif­
ference in outcome between the treatment groups is more 
likely a result of the intervention being investigated. When 
designing and evaluating the results of an RCT in which a 
surgical procedure is evaluated, each surgeon's experience 
with the technique must be considered. For example, in the 
EC-IC Bypass Study,9 "' surgeons were required to demon­
strate the achievement of at least 80% graft patency in at 
least 10 consecutive EC-IC procedures. In this way, the 
designers of the trial controlled for surgical inexperience as 
a potential confounder prior to the initiation of the study If 
it is not possible to control for surgical experience prior to 
beginning the trial, this variable should be analyzed during 
and at the conclusion of the trial. Often both methods are 
used to assess surgical experience.
The timing of trials is an important issue. All surgeons 
would agree that innovative, new surgical procedures are 
associated with a learning curve, a phenomenon that re­
flects the change in success rate over time. Mistakes and
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modifications involving the procedure may occur during 
the early part of the learning curve until the procedure has 
been sufficiently refined. The slope and length of different 
portions of the learning curve primarily depend on a sur­
geon's experience and the complexity of the procedure 
itself as well as other factors such as improved technolo­
gy and facilities. If a clinical trial is started at the begin­
ning of the curve, a false-negative result may be obtained 
simply because the surgeons have not yet perfected the 
procedure. In the ESIT, participating surgeons were re­
quired to have performed five or more endoscopic shunt 
procedures; however, this may not have assured technical 
proficiency Therefore, it is possible that the shunt sur­
vival rate at the beginning of the trial was low simply 
because surgeons had to learn how to use the endoscope. 
To investigate this possibility, we hypothesized that if the 
trial was initiated before the participating surgeons had 
acquired adequate experience with the endoscope, we 
might observe evidence of “learning" during the trial. In 
other words, if the surgeons were learning during the trial, 
we would find better results at higher-volume centers 
and/or improved results as the course of the accrual peri­
od progressed. Absence of either of these phenomena 
would indicate that the trial was not conducted during the 
learning phase for the procedure and that the negative 
result is valid.
Clinical M aterial and M ethods
The detailed methods of the ESIT have been published 
previously.15 The accrual period for the trial was 3.5 years. 
To test our hypothesis, demographic data were collected for 
patients randomized to the endoscope-treated group during 
the I st and last years of the trial. Data included age at regis­
tration (in days), sex, whether the patient was bom with 
a myelomeningocele, head circumference at time of regis­
tration (in centimeters), and the mean shunt survival (in 
years). Kaplan-Meier survival curves pertaining to the 
shunts themselves were calculated for each treatment group. 
To determine whether there was a learning curve for the 
endoscope, the trial accrual period was divided into seven 6- 
month intervals. One-year shunt survival rates for each of 
these intervals were calculated.
The effect of the center's treatment volume was evalu­
ated by constructing a Cox multivariate proportional haz­
ard regression model. Variables assessed in the model 
were age at registration, the presence of a myelomeningo­
cele, head size at time of registration, whether the shunt 
was placed with the aid of an endoscope, and the center's 
treatment volume (number of study participants provided 
by that center). Age, head circumference, and center vol­
ume were kept as continuous or discrete variables. Sta­
tistical significance occurred at probability levels less than
0.05. All statistical calculations were conducted using Stata 
software (version 8 ; Stata Corp., College Station, TX).
Results
The results of the ESIT will be briefly summarized. Eli­
gible patients were younger than 18 years of age, exhibit­
ed clinical and radiographic evidence of hydrocephalus, 
and required a cerebrospinal fluid diversion procedure. 
During a 3.5-year period, 393 (214 male and 179 female)
Demographic data obtained in patients randomized to the 
endoscope treatment arm for the 1st and last years o f the ESIT
TABLE 1
Period in the Study (%)
Variable 1 st Year Last Year
no. of cases 32 61
male 17(53.3) 27 (44.3)
median age at registration (days) 71.5 72
myelomeningocele 13 (40.6) 15 (24.6)
median head circumference (cm) 40.9 40.5
median shunt survival (yrs) 1.22 0.93
patients were randomized: 194 to the endoscopic treat­
ment arm and 199 to the conventional insertion ann. The 
primary end point was shunt failure, defined as obstruc­
tion, overdrainage, loculation, or infection. The overall I - 
and 2-year incidences of shunt failure were 0.38 and 0.47, 
respectively. The I-year shunt survival was 0.58 in the 
endoscope group and 0.66  in the nonendoscope group (log 
rank = 2.92, p = 0.09).17
The demographic data obtained in patients randomized 
in the 1 st and last years of the trial are summarized in 
Table I. There were 32 patients in the I st year compared 
with 61 in the last year. The two cohorts were similar in 
terms of age, sex, and head circumference at registration, 
although there were more patients harboring a myelomen­
ingocele in the I st-year cohort. The median I -year shunt 
survival rate for the I st- and last-year patients were 1 .22  
and 0.93, respectively
There was no significant difference in shunt survival in 
cases in which the endoscope was used when I st- and last- 
year data were compared (log rank = 0.08, p = 0.77; Fig. 
I). The I -year shunt survival rates for each of the 6 -month 
intervals are shown in Fig. 2. There was no sustained 
improvement in the survival rates during the study. The 
results of the Cox proportional hazard model analysis are 
shown in Table 2. No factor, including center volume, was 
found to be statistically significant. Only head circumfer­
ence was indicative of predicting shunt failure (p = 0.053).
Discussion
Clinical trials in which a new surgical procedure is 
being evaluated are more complex to design than the typ­
ical medical or drug trial for various reasons.1117- 6-31'-31 
Standardizing the procedure of interest may be difficult, 
especially as the complexity of the procedure increases. 
Blinding is often impossible. There are ethical issues 
unique to surgical trials, such as allowing chance to deter­
mine whether a patient will undergo an invasive procedure 
and offering a placebo or sham surgery Accruing patients 
in surgical trials is more challenging. Experience and 
learning associated with the surgical intervention and their 
relationship to the timing of the trial must be taken into 
account. These and other components of an RCT are 
important enough that investigators often present and pub­
lish their methodology prior to initiating the trial.11'-18- 2
Most procedures have an associated learning curve, 
which can have significant impact on patient care. 12- 9 In 
general, a successful procedure-related outcome is more 
likely after mistakes have been corrected and modifica-
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Fig. 1. Graph showing Kaplan-Meier curves. The shunt failure 
rate in 93 endoscope-treated patients accrued during the 1st year 
(solid line) and last year (dotted line) of the trial are depicted.
Fig. 2. Graph demonstrating 1-year shunt survival rates for each 
of the seven 6-month intervals of the trial. K-M = Kaplan-Meier.
tions made. Learning curves have been investigated for 
many new procedures such as endovascular repair of ab­
dominal aortic aneurysms, 16 breast cancer lymphatic map­
ping,1 laparoscopic colectomy28 and cholecystectomy,20 
transurethral ultrasonography-guided laser-induced pro­
statectomy,27 and sutureless intestinal anastomosis.8 There 
are numerous examples within the neurosurgical literature 
that underscore a positive volume and experience-out- 
come relationship.2’5 25 For example, a carotid endarterec- 
tomy confers a protective benefit in patients with steno­
sis greater than 60% only if the perioperative combined 
morbidity and mortality rates are less than 3 and 6% 
for asymptomatic and symptomatic patients, respective­
l y  11,19,21 Mortality rates were found to be lower in higher- 
volume centers when patients underwent surgery for ruptur­
ed and unruptured aneurysms.67 Ramsay, et al.,23 published 
a comprehensive review in which they described how learn­
ing curves have been assessed for emerging health technol­
ogy. They found 272 studies that met their inclusion criteria. 
In 51% of the studies minimally invasive surgeries were 
assessed, and 95% of the articles were case series. In only 
2% of the studies were data collected from RCTs. The 
authors found that the statistical methods used to assess 
learning have almost always been crude, such as descrip­
tive data without formal statistical testing. In fact, Ram­
say, et al.,24 found that learning curves described in non­
medical fields such as engineering and psychology often 
provided more sophisticated methods.
The presence or absence of a learning curve and its 
effect on the timing of the trial is important. Chalmers 
strongly believed tha t44. . .  from the scientific, ethical, and 
practical standpoint, exploration of any new therapy in 
sick patients should begin with randomization into either 
the conventional or the new treatment regimen.” 4 If the 
trial is conducted too early, however, success rates may be 
artificially suppressed simply because participating sur­
geons are unfamiliar with the procedure and are still 
“learning.” Some authors have argued that surgical trials 
should be conducted only after the pertinent intervention 
has been perfected (or as nearly as possible) and the slope 
of the learning curve is nearing zero. By the time the pro­
cedure has been perfected, however, clinical equipoise 
may have disappeared as people become convinced of the 
procedure’s effectiveness based on poor evidence. Such a 
paradox is known as the Buxton law, in which the follow­
ing is stated: “It is always too early for rigorous evaluation 
until, unfortunately, it’s suddenly too late.” 3
Based on our analyses, we found no evidence to indi­
cate that the participating surgeons were learning during 
the trial. The survival of the shunt was similar for endo­
scope-treated patients accrued in the 1 st and last years of 
the trial. This finding was true despite the fact that myelo­
meningocele is a risk factor for shunt failure and there 
were more patients with myelomeningocele entered in the 
1st year of the study. Furthermore, center volume was not 
found to be predictive of shunt survival in the Cox multi­
variate proportional hazard model. Interestingly, head cir­
cumference was the only variable that may be related to 
shunt failure. Thus, we believe that the results of the ESIT 
are valid; the negative result cannot be attributed to lack 
of surgeon experience or the trial being performed too 
early.
When designing a trial in which surgical experience and 
learning could potentially distort the true effect of the sur­
gical intervention, the investigators should be aware of the 
procedure’s learning curve and its potential impact on the 
outcome of the trial. Based on published and pilot data 
(such as a prerandomization phase of observational data 
collection), it may be possible to determine whether the
TABLE 2
Summary o f data derived from the 
Cox multivariate proportional hazard model
Variable Hazard Ratio p Value
age at registration 1.00 0.57
myelomeningocele 0.83 0.74
shunt placement 1.19 0.29
center volume 1.00 0.74
head circumference 0.97 0.05
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results of a particular procedure are stable or improving 
over time.’3 The trial design may minimize the potential 
for learning by imposing rigid entry criteria for surgeons 
as was done in the EC-IC bypass trial.9 Alternatively, the 
presence and impact of learning can be assessed in a post 
hoc fashion as in the Shunt Design Trial. 14 In that trial, 
various shunt systems were evaluated; the primary out­
come was shunt failure. Because two of the valves were 
new at the time of the study, it was possible that the sur­
geons had to learn how to place them and this learning 
process might have affected the results. Shunt failure was 
subsequently analyzed both chronologically (early com­
pared with late phases of the trial) and in terms of center 
volume. As in our analysis, learning did not affect the re­
sults. nevertheless, failure to account for a learning curve 
may lead to inaccurate study results in some instances and, 
potentially, the abandonment of a beneficial procedure.
Conclusions
The failure of endoscopic assistance to improve shunt 
survival in the ESIT was not due to inexperience with the 
endoscope. No appreciable learning curve existed, and 
center volume had no effect on outcome.
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